The CBM-opathies—A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
Open Access
- 19 September 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 2078
Abstract
The caspase recruitment domain family member 11 (CARD11 or CARMA1)—B cell CLL/lymphoma 10 (BCL10)—MALT1 paracaspase (MALT1) [CBM] signalosome complex serves as a molecular bridge between cell surface antigen receptor signaling and the activation of the NF-κB, JNK, and mTORC1 signaling axes. This positions the CBM complex as a critical regulator of lymphocyte activation, proliferation, survival, and metabolism. Inborn errors in each of the CBM components have now been linked to a diverse group of human primary immunodeficiency diseases termed “CBM-opathies.” Clinical manifestations range from severe combined immunodeficiency to selective B cell lymphocytosis, atopic disease, and specific humoral defects. This surprisingly broad spectrum of phenotypes underscores the importance of “tuning” CBM signaling to preserve immune homeostasis. Here, we review the distinct clinical and immunological phenotypes associated with human CBM complex mutations and introduce new avenues for targeted therapeutic intervention.Keywords
Funding Information
- Canadian Institutes of Health Research
- BC Children’s Hospital Foundation
- Michael Smith Health Research BC
- National Institutes of Health
- Canadian Allergy, Asthma, and Immunology Foundation
- Genome British Columbia
This publication has 163 references indexed in Scilit:
- Familial Pityriasis Rubra Pilaris Is Caused by Mutations in CARD14The American Journal of Human Genetics, 2012
- Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in PsoriasisThe American Journal of Human Genetics, 2012
- PSORS2 Is Due to Mutations in CARD14The American Journal of Human Genetics, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to cause allergyJournal of Allergy and Clinical Immunology, 2011
- T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1The EMBO Journal, 2011
- NF-κB signaling pathways regulated by CARMA family of scaffold proteinsCell Research, 2010
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaNature, 2010
- Differential requirement for CARMA1 in agonist‐selected T‐cell developmentEuropean Journal of Immunology, 2009
- The CARMA1-Bcl10 Signaling Complex Selectively Regulates JNK2 Kinase in the T Cell Receptor-Signaling PathwayImmunity, 2007